Recruiting Heart Failure Studies in New York
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
This study aims to compare the efficacy of vericiguat versus placebo on change in n-terminal pro-brain natriuretic peptide (NTproBNP) from baseline to Week 16 of the Base Period. The primary hypothesi...
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
This is a Phase 2 dose-finding study in adult participants with symptomatic HFpEF....
About Heart Failure Clinical Trials in New York
Heart failure is a chronic condition where the heart cannot pump blood efficiently to meet the body's needs. It affects millions of people worldwide and can result from various heart conditions. Treatment includes medications, lifestyle changes, devices, and in severe cases, heart transplant.
There are currently 2 heart failure clinical trials recruiting participants in New York, NEW%20YORK. These studies are seeking a combined 402 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Cytokinetics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Heart Failure Clinical Trials in New York — FAQ
Are there heart failure clinical trials in New York?
Yes, there are 2 heart failure clinical trials currently recruiting in New York, NEW%20YORK. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New York?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.
Are clinical trials in New York free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.
What heart failure treatments are being tested?
The 2 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for heart failure.
Data updated March 2, 2026 from ClinicalTrials.gov